Mobile Menu - OpenMobile Menu - Closed

Hearing on "The Path Forward: Advancing Treatments and Cures for Neurodegenerative Diseases"

Date: 
Thursday, July 29, 2021 - 11:00am
Location: 
Hybrid Hearing in the John D. Dingell Room, 2123 of the Rayburn House Office, and Cisco Webex

The Subcommittee on Health of the Committee on Energy and Commerce held a hybrid hearing that included both in-person and remote attendance on Thursday, July 29, 2021, at 11:00 a.m. This hearing took place in the John D. Dingell Room, 2123 of the Rayburn House Office Building, as well as remotely using Cisco Webex online video conferencing. The hearing is entitled, "The Path Forward: Advancing Treatments and Cures for Neurodegenerative Diseases."

 

Key Documents

Memorandum from Chairman Pallone to the Subcommittee on Health

Opening Statement from Chairman Pallone as prepared for delivery

Opening Statement from Subcommittee Chairwoman Eshoo as prepared for delivery

 

Livestream

 

Witnesses

Panel I

Patrizia Cavazzoni, M.D.
Director, Center for Drug Evaluation and Research
U.S. Food and Drug Administration

Testimony

 

Richard J. Hodes, M.D.
Director, National Institute on Aging
National Institute of Health

 

Walter J. Koroshetz, M.D.
Director, National Institute of Neurological Disorders and Stroke
National Institute of Health

 

Testimony of the National Institute of Health

 

Panel II

Jinsy Andrews, M.D.
Director of Neuromuscular Clinical Trials
Neurological Institute of New York
Associate Professor of Neurology
Columbia University Vagelos College of Physicians and Surgeons

Testimony

 

Kala Booth
Huntington's Disease Caregiver and Patient

Testimony

 

Merit Cudkowicz, M.D.
Director, Sean M. Healy and AMG Center for ALS
Chief, Neurology Department
Massachusetts General Hospital
Julianne Dorn Professor of Neurology
Harvard Medical School

Testimony

 

Cartier Esham, Ph.D.
Executive Vice President, Emerging Companies
Senior Vice President, Science and Regulatory Affairs
Biotechnology Innovation Organization

Testimony

 

Yvonne Latty
Caregiver

Testimony

 

Brian Wallach
Co-Founder
I AM ALS

Testimony

 

Issues: